2023
DOI: 10.35366/108620
|View full text |Cite
|
Sign up to set email alerts
|

El resurgimiento del metoxiflurano en México

Abstract: RESUMEN.El metoxiflurano es un anestésico halogenado que se utilizó hace varias décadas para anestesia general balanceada y que actualmente está indicado para otorgar sedación controlada por el paciente. Este medicamento se encuentra actualmente a la venta en la República Mexicana, por lo que recordar las características que lo hacen diferente a otros halogenados, su farmacocinética y su utilidad para distintos escenarios proporciona el conocimiento adecuado para su uso en la práctica clínica. ABSTRACT.Methoxy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 15 publications
0
0
0
Order By: Relevance
“…However, a retrospective comparative observational study with a followup of up to 14 years did not show an increased risk of liver or kidney disease in patients who received methoxyflurane as a low-dose analgesic [13,14]. The low concentrations at which it is administered usually keep the patients conscious and rarely require airway manipulation, unlike deep intravenous sedation [13][14][15]. These are the doses administered to the group whose fractures were reduced with this anesthetic without the presence of pain.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…However, a retrospective comparative observational study with a followup of up to 14 years did not show an increased risk of liver or kidney disease in patients who received methoxyflurane as a low-dose analgesic [13,14]. The low concentrations at which it is administered usually keep the patients conscious and rarely require airway manipulation, unlike deep intravenous sedation [13][14][15]. These are the doses administered to the group whose fractures were reduced with this anesthetic without the presence of pain.…”
Section: Discussionmentioning
confidence: 91%
“…However, the duration of followup is limited, and the number of hepatic and renal events reported in routine pharmacovigilance is too small to draw reliable conclusions. However, a retrospective comparative observational study with a followup of up to 14 years did not show an increased risk of liver or kidney disease in patients who received methoxyflurane as a low-dose analgesic [13,14]. The low concentrations at which it is administered usually keep the patients conscious and rarely require airway manipulation, unlike deep intravenous sedation [13][14][15].…”
Section: Discussionmentioning
confidence: 99%